Using multiple samples from more than 60,000 individuals at a participating hospital, the firm tracks circulating molecules over time in relation to cancer.
Some 50 groups have signed a letter expressing strong opposition to a bill that would allow workplace wellness programs to collect employees' genetic information.
The company said it had 53 of its Atlas molecular diagnostic systems placed with customers under commercial agreements as of the end of 2016.
The company will pay nearly $2.1 million to the liquidating trust for the now-bankrupt HDL in order to resolve outstanding debt from a former joint lab venture.
International research teams collaborated to create five fully functioning synthetic yeast chromosomes, taking them one step closer to a whole synthetic genome.
The Alabama Genomic Health Initiative aims to recruit participants from every county in the state and provide genomic analysis and interpretation free of charge.
The collaborators aim to create a genomic reference catalog for up to 1,000 plants used in traditional Chinese medicine.
Progenetics will distribute GeneStrat and Veristrat liquid biopsy tests in Israel, making Biodesix's tests available in the Middle East for the first time.
The companies aim to develop a genomic test to differentiate respiratory allergens from irritants to help with drug discovery.
The collaboration aims to correlate extremely high performance scores on Lumos' memory tests with genetic variations.
Privately held TransCell specializes in primary cell-based phenotypic screening assays.
An analysis of Aboriginal Australian samples stretching back to the 1920s suggests these populations may have been on the continent for up to 50,000 years.
Eight draft microbial genomes were generated using DNA in Neanderthal plaque, as part of study aimed at uncovering Neanderthal diet, behavior, and more.
Laboratoire Cerba was granted the right to develop a tumor expression test based on IntegraGen's proprietary microRNA biomarker.
The lawsuits allege the company failed to disclose information or made misleading statements about a $12 million donation.
The collaboration will streamline patient sample analysis to determine whether they should be included in clinical trials for molecularly targeted treatment.
Using mass spec analysis to measure phosphorylation levels in EV proteins, the researchers identified 144 proteins showing increased phosphorylation in cancer.
The German Association of Gynecological Oncology included the breast cancer diagnostic in its annual update for cancer clinicians.
MLL will be the first European user of Illumina's new high-throughput sequencing platform, the NovaSeq.
Under the terms of the collaboration, the firms will combine ZS Genetics' proprietary technologies with HTA's experience in high-resolution electron microscopy.
The company said it will use the net proceeds to redeem the outstanding $500 million aggregate principal amount of senior notes maturing in January 2018.
Natera saw total Q4 2016 revenues decline to $49.3 million, despite an increase in testing volumes.
The companies will work together to develop and market an automated ultra high-throughput sample preparation system based on their respective technologies.
Startup companies are taking on personalized medicine, CNET reports.
Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.
The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.
In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.